IP Library Patent Application 12265541
Patent Application
App. No. 12/265,541

Neural Signal Processing

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/265,541
Abstract

A method of monitoring neural signal activity with an implantable monitoring device implanted in a living subject includes amplifying a neural signal having a signal bandwidth of at least 1000 Hz. The method also includes processing the amplified neural signal to produce a reduced-bandwidth derivative neural signal representative of gross activity of the neural signal, and wirelessly transmitting the derivative neural signal from the implantable monitoring device for receipt by a receiver external of the living subject.

Claims (29)

1 . A method of monitoring neural signal activity with an implantable monitoring device implanted in a living subject, comprising:

amplifying a neural signal having a signal bandwidth of at least 1000 Hz;

processing the amplified neural signal to produce a reduced-bandwidth derivative neural signal representative of gross activity of the neural signal; and

wirelessly transmitting the derivative neural signal from the implantable monitoring device for receipt by a receiver external of the living subject.

2 . The method of claim 1 , wherein the derivative neural signal has a signal bandwidth of less than about 250 Hz.

3 . The method of claim 1 , further comprising sampling the amplified neural signal and wirelessly transmitting the sampled signal for receipt by a receiver external of the living subject, wherein the sampling preserves full bandwidth of the amplified neural signal.

4 . The method of claim 3 , wherein transmission of the derivative neural signal and the full-bandwidth sampled signal occurs simultaneously.

5 . The method of claim 1 , wherein processing the amplified neural signal includes rectifying and integrating the amplified neural signal.

6 . The method of claim 1 , wherein processing the amplified neural signal includes detecting successive local extrema of the amplified neural signal.

7 . The method of claim 1 , further comprising determining and subtracting an offset from the derivative neural signal, where the offset represents a contribution of noise to the derivative neural signal.

8 . The method of claim 1 , further comprising using the derivative neural signal to modulate a periodic waveform.

9 . The method of claim 1 , wherein the neural signal is accessed using electrodes in contact with a renal nerve of the living subject.

10 . The method of claim 1 , further comprising assessing the derivative neural signal to predict occurrence of a future physiological change for the living subject.

11 . An implantable monitoring device, comprising:

an acquisition circuit configured to amplify a neural signal having a signal bandwidth of at least 1000 Hz;

a processing circuit configured to process the amplified neural signal to produce a derivative neural signal representative of gross activity of the neural signal; and

a transmitter circuit configured to wirelessly transmit the derivative neural signal from the implantable monitoring device for receipt by a receiver external of the living subject.

12 . The implantable monitoring device of claim 11 , further comprising a control circuit that when activated causes the transmitter circuit to wirelessly transmit the amplified neural signal for receipt by a receiver external of the living subject.

13 . The implantable monitoring device of claim 12 , further comprising a second transmitter circuit, and wherein transmission of the derivative neural signal and the amplified neural signal occurs simultaneously over the transmitter circuit and second transmitter circuit, respectively.

14 . The implantable monitoring device of claim 11 , wherein the processing circuit is configured to rectify and integrate the amplified neural signal.

15 . The implantable monitoring device of claim 11 , wherein the processing circuit is configured to detect successive local extrema of the amplified neural signal.

16 . The implantable monitoring device of claim 11 , wherein the processing circuit is configured to determine and subtract an offset from the derivative neural signal, where the offset represents a contribution of noise to the derivative neural signal.

17 . The implantable monitoring device of claim 11 , further comprising a modulator to modulate a periodic waveform using the derivative neural signal.

18 . The implantable monitoring device of claim 11 , wherein the neural signal is accessed using electrodes in contact with a renal nerve of the living subject.

19 . The implantable monitoring device of claim 11 , wherein the acquisition circuit and the processing circuit are housed in a first enclosure, the transmitter circuit is housed in a second enclosure, and wherein the derivative neural signal is passed from an output of the first enclosure to an input of the second enclosure.

20 . The implantable monitoring device of claim 19 , wherein the second enclosure houses circuitry for monitoring one or more vital signs of an implanted subject, and wherein the input of the second enclosure is a biopotential input.

21 . A method of monitoring neural signal activity with an implantable monitoring device implanted in a living subject, comprising:

sampling a neural signal, having a signal bandwidth of at least 1000 Hz, at a predetermined sampling frequency less than a Nyquist frequency for the neural signal to produce an undersampled neural signal from which gross activity of the neural signal can be derived; and

wirelessly transmitting the undersampled neural signal from the implantable monitoring device for receipt by a receiver external of the living subject.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 18, 2025
From: CITIZENS BANK, N.A.
To: HARVARD BIOSCIENCE, INC.; DATA SCIENCES INTERNATIONAL, INC.
Reel/Frame 074022/0661 →
SECURITY INTEREST Recorded Dec 28, 2020
From: HARVARD BIOSCIENCE, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 054855/0481 →
CHANGE OF NAME Recorded Feb 18, 2011
From: TRANSOMA MEDICAL, INC.
To: DATA SCIENCES INTERNATIONAL, INC.
Reel/Frame 025831/0796 →
SECURITY AGREEMENT Recorded May 14, 2009
From: DATA SCIENCES INTERNATIONAL, INC.
To: PARTNERS FOR GROWTH II, L.P.
Reel/Frame 022678/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2009
From: MILLS, PERRY A.; BROCKWAY, MARINA V.; BROCKWAY, BRIAN P.
To: TRANSOMA MEDICAL, INC.
Reel/Frame 022082/0918 →